Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

about

Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.

P2860

Q40066352-86BB5E8B-2E48-4A29-94F6-24328B4B802E

P2860

Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

Item

http://www.wikidata.org/entity/Q37615936

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study

@en

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study.

@nl

type

Item

label

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study

@en

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study.

@nl

prefLabel

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study

@en

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study.

@nl

P1476

Serum levels of interleukin-22 ...... 2 diabetes: KORA F4/FF4 study

@en

P2093

Christian Herder

http://www.w3.org/2001/XMLSchema#string

Julia M Kannenberg

http://www.w3.org/2001/XMLSchema#string

Maren Carstensen-Kirberg

http://www.w3.org/2001/XMLSchema#string

Michael Roden

http://www.w3.org/2001/XMLSchema#string

Wolfgang Rathmann

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes

Interleukin-22 in kidney injury and regeneration.

The IL-20 subfamily of cytokines--from host defence to tissue homeostasis

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study.

Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.

In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

Interleukin-22: immunobiology and pathology.

P2888

s12933-017-0498-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0498-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maren Carstensen-Kirberg

Cornelia Huth

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083399574

http://www.w3.org/2001/XMLSchema#string

P698

28143481

http://www.w3.org/2001/XMLSchema#string

P921

interleukin

type-2 diabetes

P932

5282888

http://www.w3.org/2001/XMLSchema#string

Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

about

P2860

P2860

Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932